packagePirtobrutinib

pirtobrutinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Pirtobrutinib is a Bruton's tyrosine kinase inhibitor used to treat mantle cell lymphoma and chronic lymphocytic leukemia. It is an approved medicine and is authorised in the European Union for mantle cell lymphoma.

Summary written by glm-5.3-flash from Wikidata Q116622551 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:pirtobrutinib
ATC codes:L01EL05
DrugBank:DB17472
PubChem CID:129269915
Wikidata:Q116622551
formula:C22H21F4N5O3
molar mass:479.434 g/mol (PubChem CID 129269915)
logP:3.3 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown